b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="Publisher" Owner="NLM">\n        <PMID Version="1">32319222</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>04</Month>\n            <Day>22</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">2410-8650</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Apr</Month>\n                        <Day>22</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>The Kaohsiung journal of medical sciences</Title>\n                <ISOAbbreviation>Kaohsiung J. Med. Sci.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>The potential function of miR-135b-mediated JAK2/STAT3 signaling pathway during osteoblast differentiation.</ArticleTitle>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1002/kjm2.12217</ELocationID>\n            <Abstract>\n                <AbstractText>MC3T3-E1 cells were divided into Blank, miR-135b mimics, miR-135b inhibitors, AG490, and miR-135b inhibitors + AG490 groups. Cell viability was determined by MTT, alkaline phosphatase (ALP) activity by the corresponding kit, and mineralization by alizarin red staining. Furthermore, miR-135b, osteoblast-specific genes, and JAK2/STAT3 were detected through quantitative real-time polymerase chain reaction and Western blotting. MiR-135b downregulation was identified with increased JAK2 during osteoblast differentiation. JAK2 was confirmed as a target gene of miR-135b by dual-luciferase reporter assay. MC3T3-E1 cells in both miR-135b mimics and AG490 groups manifested decrease in cell viability, ALP activity, and mineralized nodes, as well as reductions in osteoblast-specific genes and proteins of JAK2, p-JAK2, and p-STAT3, but increase in cell apoptosis. However, opposite changes of the above factors were shown in cells from miR-135b inhibitors group. Notably, AG490 could reverse promotion effects of miR-135b inhibitors on osteoblast differentiation. Inhibiting miR-135b could activate the JAK2/STAT3 signaling pathway, thereby improving the cell viability and promoting the osteoblast differentiation.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2020 The Authors. The Kaohsiung Journal of Medical Sciences published by John Wiley &amp; Sons Australia on behalf of Kaohsiung Medical University.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Zhang</LastName>\n                    <ForeName>Xiang-Tao</ForeName>\n                    <Initials>XT</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Orthopedics, The No.1 Hospital of Shijiazhuang, Shijiazhuang, Hebei, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sun</LastName>\n                    <ForeName>Min</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neonatology, Children\'s Hospital of Hebei Province, Shijiazhuang, Hebei, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhang</LastName>\n                    <ForeName>Li</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>The second Department of Orthopedics, The Third Hospital of Hebei Medical University &amp; You Yi Branch, Shijiazhuang, Hebei, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Dai</LastName>\n                    <ForeName>Yi-Ke</ForeName>\n                    <Initials>YK</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>The first Department of Arthrosis, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Fei</ForeName>\n                    <Initials>F</Initials>\n                    <Identifier Source="ORCID">https://orcid.org/0000-0002-8399-9766</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>The first Department of Arthrosis, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2020</Year>\n                <Month>04</Month>\n                <Day>22</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>China (Republic : 1949- )</Country>\n            <MedlineTA>Kaohsiung J Med Sci</MedlineTA>\n            <NlmUniqueID>100960562</NlmUniqueID>\n            <ISSNLinking>1607-551X</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">JAK2/STAT3</Keyword>\n            <Keyword MajorTopicYN="N">MC3T3-E1 cells</Keyword>\n            <Keyword MajorTopicYN="N">miR-135b</Keyword>\n            <Keyword MajorTopicYN="N">osteoblast differentiation</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>09</Month>\n                <Day>02</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2020</Year>\n                <Month>01</Month>\n                <Day>31</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2020</Year>\n                <Month>03</Month>\n                <Day>23</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>aheadofprint</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">32319222</ArticleId>\n            <ArticleId IdType="doi">10.1002/kjm2.12217</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Title>REFERENCES</Title>\n            <Reference>\n                <Citation>Rivadeneira F, Makitie O. Osteoporosis and bone mass disorders: From gene pathways to treatments. Trends Endocrinol Metab. 2016;27(5):262-281.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Zhang Y, Gao Y, Cai L, Li F, Lou Y, Xu N, et al. MicroRNA-221 is involved in the regulation of osteoporosis through regulates RUNX2 protein expression and osteoblast differentiation. Am J Transl Res. 2017;9(1):126-135.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337-342.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lima GA, Paranhos Neto FP, Pereira GR, Gomes CP, Farias ML. Osteoporosis management in patient with renal function impairment. Arq Bras Endocrinol Metabol. 2014;58(5):530-539.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Li J, He X, Wei W, Zhou X. MicroRNA-194 promotes osteoblast differentiation via downregulating STAT1. Biochem Biophys Res Commun. 2015;460(2):482-488.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Du F, Wu H, Zhou Z, Liu YU. microRNA-375 inhibits osteogenic differentiation by targeting runt-related transcription factor 2. Exp Ther Med. 2015;10(1):207-212.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Goettsch C, Rauner M, Pacyna N, Hempel U, Bornstein SR, Hofbauer LC. miR-125b regulates calcification of vascular smooth muscle cells. Am J Pathol. 2011;179(4):1594-1600.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Eskildsen T, Taipaleenmaki H, Stenvang J, Abdallah BM, Ditzel N, Nossent AY, et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci U S A. 2011;108(15):6139-6144.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Huang J, Zhao L, Xing L, Chen D. MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells. 2010;28(2):357-364.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Schaap-Oziemlak AM, Raymakers RA, Bergevoet SM, Gilissen C, Jansen BJ, Adema GJ, et al. MicroRNA hsa-miR-135b regulates mineralization in osteogenic differentiation of human unrestricted somatic stem cells. Stem Cells Dev. 2010;19(6):877-885.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Li Z, Hassan MQ, Volinia S, van Wijnen AJ, Stein JL, Croce CM, et al. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A. 2008;105(37):13906-13911.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Kwak HB, Sun HM, Ha H, Lee JH, Kim HN, Lee ZH. AG490, a Jak2-specific inhibitor, induces osteoclast survival by activating the Akt and ERK signaling pathways. Mol Cells. 2008;26(5):436-442.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Luan HF, Zhao ZB, Zhao QH, Zhu P, Xiu MY, Ji Y. Hydrogen sulfide postconditioning protects isolated rat hearts against ischemia and reperfusion injury mediated by the JAK2/STAT3 survival pathway. Braz J Med Biol Res. 2012;45(10):898-905.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Itoh S, Udagawa N, Takahashi N, Yoshitake F, Narita H, Ebisu S, et al. A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation. Bone. 2006;39(3):505-512.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Guo L, Luo T, Fang Y, Yang L, Wang L, Liu J, et al. Effects of erythropoietin on osteoblast proliferation and function. Clin Exp Med. 2014;14(1):69-76.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Yu X, Li Z, Wan Q, Cheng X, Zhang J, Pathak JL, et al. Inhibition of JAK2/STAT3 signaling suppresses bone marrow stromal cells proliferation and osteogenic differentiation, and impairs bone defect healing. Biol Chem. 2018;399(11):1313-1323.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Langenbach F, Handschel J. Effects of dexamethasone, ascorbic acid and beta-glycerophosphate on the osteogenic differentiation of stem cells in vitro. Stem Cell Res Ther. 2013;4(5):117.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Fan JB, Ruan JW, Liu W, Zhu LQ, Zhu XH, Yi H, et al. miR-135b expression downregulates Ppm1e to activate AMPK signaling and protect osteoblastic cells from dexamethasone. Oncotarget. 2016;7(43):70613-70622.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Shao PL, Wu SC, Lin ZY, Ho ML, Chen CH, Wang CZ. Alpha-5 integrin mediates simvastatin-induced osteogenesis of none marrow mesenchymal stem cells. Int J Mol Sci. 2019;20(3):E506.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lin SY, Kang L, Wang CZ, Huang HH, Cheng TL, Huang HT, et al. (\xe2\x88\x92)-Epigallocatechin-3-Gallate (EGCG) enhances osteogenic differentiation of human bone marrow mesenchymal stem cells. Molecules. 2018;23(12):3221.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Tai IC, Wang YH, Chen CH, Chuang SC, Chang JK, Ho ML. Simvastatin enhances Rho/actin/cell rigidity pathway contributing to mesenchymal stem cells\' osteogenic differentiation. Int J Nanomed. 2015;10:5881-5894.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Joung YH, Lim EJ, Darvin P, Chung SC, Jang JW, Do Park K, et al. MSM enhances GH signaling via the Jak2/STAT5b pathway in osteoblast-like cells and osteoblast differentiation through the activation of STAT5b in MSCs. PLoS One. 2012;7(10):e47477.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Gong Q, Wang R, Jiang H, Lin Z, Ling J. Alteration of microRNA expression of human dental pulp cells during odontogenic differentiation. J Endod. 2012;38(10):1348-1354.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Han SH, Jang G, Bae BK, Han SM, Koh YR, Ahn JO, et al. Effect of ectopic OCT4 expression on canine adipose tissue-derived mesenchymal stem cell proliferation. Cell Biol Int. 2014;38(10):1163-1173.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Li D, Deng T, Li H, Li Y. MiR-143 and miR-135 inhibitors treatment induces skeletal myogenic differentiation of human adult dental pulp stem cells. Arch Oral Biol. 2015;60(11):1613-1617.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Cao L, Wang J, Hou J, Xing W, Liu C. Vascularization and bone regeneration in a critical sized defect using 2-N,6-O-sulfated chitosan nanoparticles incorporating BMP-2. Biomaterials. 2014;35(2):684-698.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>McGee-Lawrence ME, Carpio LR, Bradley EW, Dudakovic A, Lian JB, van Wijnen AJ, et al. Runx2 is required for early stages of endochondral bone formation but delays final stages of bone repair in Axin2-deficient mice. Bone. 2014;66:277-286.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Ediz L, Hiz O, Meral I, Alpayci M. Complex regional pain syndrome: A vitamin K dependent entity? Med Hypotheses. 2010;75(3):319-323.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Gordon JA, Tye CE, Sampaio AV, Underhill TM, Hunter GK, Goldberg HA. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro. Bone. 2007;41(3):462-473.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Ortuno MJ, Ruiz-Gaspa S, Rodriguez-Carballo E, Susperregui AR, Bartrons R, Rosa JL, et al. p38 regulates expression of osteoblast-specific genes by phosphorylation of osterix. J Biol Chem. 2010;285(42):31985-31994.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>McKee MD, Nanci A. Osteopontin: an interfacial extracellular matrix protein in mineralized tissues. Connect Tissue Res. 1996;35(1-4):197-205.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Gu Q, Cai Y, Huang C, Shi Q, Yang H. Curcumin increases rat mesenchymal stem cell osteoblast differentiation but inhibits adipocyte differentiation. Pharmacogn Mag. 2012;8(31):202-208.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Li CH, Zhao JX, Sun L, Yao ZQ, Deng XL, Liu R, et al. AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis. Biochem Biophys Res Commun. 2013;435(4):533-539.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Jo S, Wang SE, Lee YL, Kang S, Lee B, Han J, et al. IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis. Arthritis Res Ther. 2018;20(1):115.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Xie XJ, Fan DM, Xi K, Chen YW, Qi PW, Li QH, et al. Suppression of microRNA-135b-5p protects against myocardial ischemia/reperfusion injury by activating JAK2/STAT3 signaling pathway in mice during sevoflurane anesthesia. Biosci Rep. 2017;37(3):BSR20170186.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Colomiere M, Findlay J, Ackland L, Ahmed N. Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin. Int J Biochem Cell Biol. 2009;41(5):1034-1045.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Cambi GE, Lucchese G, Djeokeng MM, Modesti A, Fiaschi T, Faggian G, et al. Impaired JAK2-induced activation of STAT3 in failing human myocytes. Mol Biosyst. 2012;8(9):2351-2359.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Mori K, Blanchard F, Charrier C, Battaglia S, Ando K, Duplomb L, et al. Conditioned media from mouse osteosarcoma cells promote MC3T3-E1 cell proliferation using JAKs and PI3-K/Akt signal crosstalk. Cancer Sci. 2008;99(11):2170-2176.</Citation>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'